logo

BIAF

bioAffinity·NASDAQ
--
--(--)
--
--(--)

BIAF fundamentals

bioAffinity (BIAF) released its earnings on Aug 14, 2025: revenue was 1.27M (YoY -47.05%), missed estimates; EPS was -5.1 (YoY +10.53%), missed estimates.
Revenue / YoY
1.27M
-47.05%
EPS / YoY
-5.1
+10.53%
Report date
Aug 14, 2025

Earnings

EPS
Revenue

Revenue & Expenses

BIAF has released its 2025 Q4 earnings report, with revenue of 1.59M, reflecting a YoY change of -27.85%, and net profit of -3.14M, showing a YoY change of -5.75%. The Sankey diagram below clearly presents BIAF's revenue sources and cost distribution.

Key Indicators

bioAffinity (BIAF) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

bioAffinity (BIAF)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

bioAffinity (BIAF)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

bioAffinity (BIAF)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does bioAffinity (BIAF) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track bioAffinity (BIAF) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield